KLK3 and neoplasm: Second, as there is an overall lack of molecular signatures to stratify tumor subtypes, treatment is almost exclusively based on histological architecture (Gleason score) [10,11], prostate-specific antigen (PSA) levels [12] and local disease state (TNM, WHO 2009) [13,14].